DANA-FARBER CANCER INSTITUTE
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1947-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.dana-farber.org/
INTENT Pilot Study - Enhancing Adherence Intentions to Endocrine Therapy
- Conditions
- Interventions
- First Posted Date
- 2024-02-07
- Last Posted Date
- 2024-06-26
- Lead Sponsor
- Dana-Farber Cancer Institute
- Target Recruit Count
- 76
- Registration Number
- NCT06246084
- Locations
- 🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
CV CARE: CardioVascular Care in PC Patients
- Conditions
- Interventions
- First Posted Date
- 2024-01-12
- Last Posted Date
- 2024-07-22
- Lead Sponsor
- Dana-Farber Cancer Institute
- Target Recruit Count
- 180
- Registration Number
- NCT06202820
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
🇺🇸Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Exercise for Gut Microbiome in Patients With Young-Onset Colorectal Cancer Undergoing Chemotherapy: The COURAGE Trial
- Conditions
- Interventions
- First Posted Date
- 2024-01-11
- Last Posted Date
- 2024-07-24
- Lead Sponsor
- Dana-Farber Cancer Institute
- Target Recruit Count
- 84
- Registration Number
- NCT06202183
- Locations
- 🇺🇸
Dana Farber Cancer Institute, Boston, Massachusetts, United States
CIML NK Cells With Venetoclax for AML
- Conditions
- Interventions
- First Posted Date
- 2023-12-01
- Last Posted Date
- 2024-02-28
- Lead Sponsor
- Dana-Farber Cancer Institute
- Target Recruit Count
- 10
- Registration Number
- NCT06152809
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
🇺🇸Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Management of Cisplatin-Ineligible Patients With Metastatic Bladder Cancer and The Role of Geriatric Assessments
- Conditions
- Interventions
- First Posted Date
- 2023-11-18
- Last Posted Date
- 2024-04-23
- Lead Sponsor
- Dana-Farber Cancer Institute
- Target Recruit Count
- 180
- Registration Number
- NCT06138561
- Locations
- 🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Preemptive CIML NK Cell Therapy After Hematopoietic Stem Cell Transplantation
- First Posted Date
- 2023-11-18
- Last Posted Date
- 2024-12-02
- Lead Sponsor
- Dana-Farber Cancer Institute
- Target Recruit Count
- 15
- Registration Number
- NCT06138587
- Locations
- 🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸Brigham and Women's Hospital, Boston, Massachusetts, United States
Prospective Screening for Pancreatic Ductal Adenocarcinoma in High-Risk Individuals
- Conditions
- Interventions
- First Posted Date
- 2023-11-08
- Last Posted Date
- 2024-02-28
- Lead Sponsor
- Dana-Farber Cancer Institute
- Target Recruit Count
- 5000
- Registration Number
- NCT06122896
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
🇺🇸Dana Farber Cancer Institute, Boston, Massachusetts, United States
Integrated Smartphone Technology to Alleviate Malignant Pain (I-STAMP) Testing
- First Posted Date
- 2023-11-07
- Last Posted Date
- 2024-10-01
- Lead Sponsor
- Dana-Farber Cancer Institute
- Target Recruit Count
- 73
- Registration Number
- NCT06117709
- Locations
- 🇺🇸
Dana Farber Cancer Institute, Boston, Massachusetts, United States
Liquid Biopsy in Ewing Sarcoma and Osteosarcoma As a Prognostic and Response Diagnostic: LEOPARD
- Conditions
- Interventions
- First Posted Date
- 2023-10-05
- Last Posted Date
- 2024-11-19
- Lead Sponsor
- Dana-Farber Cancer Institute
- Target Recruit Count
- 340
- Registration Number
- NCT06068075
- Locations
- 🇺🇸
Childrens Hospital Los Angeles, Los Angeles, California, United States
🇺🇸Children's Healthcare of Atlanta, Atlanta, Georgia, United States
🇺🇸Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States
Debunking the Frailty-sarcopenIa-ADT Axis in mEtastatic Prostate canceR With multiComponent Exercise: The FIERCE Trial
- Conditions
- Interventions
- First Posted Date
- 2023-09-15
- Last Posted Date
- 2024-02-28
- Lead Sponsor
- Dana-Farber Cancer Institute
- Target Recruit Count
- 80
- Registration Number
- NCT06040125
- Locations
- 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
🇺🇸Brigham and Women's Hospital, Boston, Massachusetts, United States
🇺🇸Dana-Farber Cancer Institute, Boston, Massachusetts, United States